DE69510192T2 - Substituierte cyclopentylaminderivate und deren verwendung als calcium-kanal antagonisten - Google Patents

Substituierte cyclopentylaminderivate und deren verwendung als calcium-kanal antagonisten

Info

Publication number
DE69510192T2
DE69510192T2 DE69510192T DE69510192T DE69510192T2 DE 69510192 T2 DE69510192 T2 DE 69510192T2 DE 69510192 T DE69510192 T DE 69510192T DE 69510192 T DE69510192 T DE 69510192T DE 69510192 T2 DE69510192 T2 DE 69510192T2
Authority
DE
Germany
Prior art keywords
calcium channel
channel antagonists
derivatives
substituted cyclopentylamine
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69510192T
Other languages
English (en)
Other versions
DE69510192D1 (de
Inventor
Thomas Brown
John HARLING
Barry Orlek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE69510192D1 publication Critical patent/DE69510192D1/de
Publication of DE69510192T2 publication Critical patent/DE69510192T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/26—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69510192T 1994-03-26 1995-03-14 Substituierte cyclopentylaminderivate und deren verwendung als calcium-kanal antagonisten Expired - Fee Related DE69510192T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9406043A GB9406043D0 (en) 1994-03-26 1994-03-26 Compounds
PCT/EP1995/000964 WO1995026327A1 (en) 1994-03-26 1995-03-14 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists

Publications (2)

Publication Number Publication Date
DE69510192D1 DE69510192D1 (de) 1999-07-15
DE69510192T2 true DE69510192T2 (de) 2000-02-24

Family

ID=10752569

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69510192T Expired - Fee Related DE69510192T2 (de) 1994-03-26 1995-03-14 Substituierte cyclopentylaminderivate und deren verwendung als calcium-kanal antagonisten

Country Status (7)

Country Link
US (1) US5817698A (de)
EP (1) EP0752981B1 (de)
JP (1) JPH09510719A (de)
AU (1) AU2071095A (de)
DE (1) DE69510192T2 (de)
GB (1) GB9406043D0 (de)
WO (1) WO1995026327A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1600599A (en) 1998-02-27 1999-09-15 Warner-Lambert Company Heterocyclic substituted aniline calcium channel blockers
US6166052A (en) * 1998-03-11 2000-12-26 Warner-Lambert Company Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
NZ507169A (en) * 1998-04-01 2004-02-27 Cardiome Pharma Corp Aminocyclohexyl ether compounds and uses thereof
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
GB9915617D0 (en) 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) * 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
DE10213051B4 (de) * 2002-03-23 2013-03-07 Grünenthal GmbH Substituierte 4-Aminocyclohexanole
US20090041841A1 (en) * 2003-05-02 2009-02-12 Cardiome Pharma Corp. Controlled release tablet formulations for the prevention of arrhythmias
BRPI0318278B8 (pt) * 2003-05-02 2024-01-09 Cardiome Pharma Corp Compostos de éter aminocicloexílico, composição compreendendo ditos compostos, usos dos mesmos e método para modular a atividade do canal iônico em um ambiente in vitro
US7345086B2 (en) * 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
WO2005018635A2 (en) * 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
US7345087B2 (en) * 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
WO2005097087A2 (en) * 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
WO2005113011A2 (en) 2004-04-01 2005-12-01 Cardiome Pharma Corp. Prodrugs of ion channel modulating compounds and uses thereof
US8263638B2 (en) * 2004-11-08 2012-09-11 Cardiome Pharma Corp. Dosing regimens for ion channel modulating compounds
US9023892B2 (en) 2009-12-21 2015-05-05 Ramiz Boulos Antimicrobial compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837226A (en) * 1988-04-27 1989-06-06 Warner-Lambert Company Polycyclic amine derivatives useful as cerebrovascular agents
GB9315566D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Medicaments
GB9315600D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
AU2071095A (en) 1995-10-17
JPH09510719A (ja) 1997-10-28
GB9406043D0 (en) 1994-05-18
EP0752981A1 (de) 1997-01-15
WO1995026327A1 (en) 1995-10-05
DE69510192D1 (de) 1999-07-15
US5817698A (en) 1998-10-06
EP0752981B1 (de) 1999-06-09

Similar Documents

Publication Publication Date Title
DE59711847D1 (de) Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung
DE59803292D1 (de) Triazolverbindungen und deren verwendung als dopamin-d 3-liganden
DE873126T1 (de) Markierte vitamin d-verbindungen und deren verwendung
DE69617236D1 (de) N-heteroaryl-pyridinsulfonamidderivate und deren verwendung als endothelinantagonisten
DE69615025T2 (de) Benzamid-derivate und deren verwendung als vasopressin-antagonisten
DE69622148T2 (de) Chinazozin derivate und deren verwendung
DE69631240D1 (de) Schaltvorrichtung und deren verwendung
DE69637691D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
DE69638056D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
DE69332898T2 (de) 4-Carboxamidopiperidinderivate und ihre Verwendung als Neurokinin Antagonisten
DE69510192T2 (de) Substituierte cyclopentylaminderivate und deren verwendung als calcium-kanal antagonisten
DE59802439D1 (de) Spiroverbindungen und deren verwendung
ATE238342T1 (de) Neue thrombin-inhibitoren, deren herstellung und verwendung
ATE186447T1 (de) Zusammensetzung und verwendung
DE69915066D1 (de) Biozide zusammensetzung und deren verwendung
DE69715192T2 (de) Chimäre isoprenoidsynthasen und deren verwendungen
DE69729570D1 (de) Fotpempfindliche zusammensetzung und deren verwendung
DE69716062T2 (de) Benzofuran-derivate und deren verwendung
DE69632678D1 (de) Harzzusammensetzung und deren verwendung
DE69704662D1 (de) Kosmetische waschmittelzusammensetzungen und deren verwendung
DE69713512D1 (de) Substituierte phtalocyanine und deren verwendung
DE59810405D1 (de) Spiroverbindungen und deren verwendung
DE69600829D1 (de) Mikrobizide Zusammensetzung und deren Verwendung
DE69631632D1 (de) Schaltvorrichtung und deren verwendung
DE59906951D1 (de) Spiroverbindungen und deren verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee